Form 4 for LFST LifeStance Health Group, Inc.
Accepted 2024-03-12 00:00:00 ET · period of report 2024-03-08 · accession 0000950170-24-030455 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-03-12 | 2024-03-08 | LFST | Burdick Kenneth A | CEO, Dir | A - Grant | $0.00 | +787.9K | 2.73M | +41% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-08 | A | A | 423,790 | $0.00 | 3,148,977 | D | — | — | (F2) Represents performance-based restricted stock units previously granted to the Reporting Person, which vested on March 8, 2024. |
| 2 | Common | Common Stock | 2024-03-08 | A | A | 364,077 | $0.00 | 2,725,187 | D | — | — | (F1) Includes 364,077 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. |